|
|
Volumn 516, Issue 729, 2014, Pages S4-S6
|
|
Drug development: Try and try again
a
a
NONE
(United States)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
DRUG DEVELOPMENT;
ADVANCED CANCER;
ARTICLE;
CANCER CHEMOTHERAPY;
CANCER DIAGNOSIS;
CANCER IMMUNOTHERAPY;
CANCER SURVIVAL;
CELL DIVISION;
DRUG APPROVAL;
DRUG COST;
DRUG DESIGN;
DRUG DEVELOPMENT;
DRUG INDUSTRY;
DRUG SCREENING;
DRUG TREATMENT FAILURE;
FATTY LIVER;
HEPATITIS;
HUMAN;
IMMUNE SYSTEM;
IMMUNOCOMPETENT CELL;
LIVER CANCER;
LIVER CELL CARCINOMA;
LIVER CIRRHOSIS;
MOLECULAR MEDICINE;
PHASE 3 CLINICAL TRIAL (TOPIC);
PRIORITY JOURNAL;
CARCINOMA, HEPATOCELLULAR;
CLINICAL TRIAL (TOPIC);
LIVER NEOPLASMS;
MORTALITY;
PATHOLOGY;
TRENDS;
CARCINOMA, HEPATOCELLULAR;
CLINICAL TRIALS AS TOPIC;
DRUG DISCOVERY;
DRUG INDUSTRY;
HUMANS;
LIVER NEOPLASMS;
|
|
EID: 84922330768
PISSN: 00280836
EISSN: 14764687
Source Type: Journal
DOI: 10.1038/516S4a Document Type: Article |
|
Times cited : (35)
|
|
References (3)
|
